Pharmacodynamics and pharmacokinetics of flumequine in pigs after single intravenous and intramuscular administration

Understanding the mechanism of interfacial interaction enhancing photodegradation rate of pollutants at molecular level: Intermolecular π-π interactions favor electrons delivery

Uncovering the interaction between photocatalyst and reaction substrate as well as subsequent electron transfer process is critical to achieve high-performance photodegradation of pollutants. Herein, based on the reduced density gradient (RDG) method, we visualize the simulation of the π-π interactions between photocatalyst (g-C₃N₄) and pollutant molecule (flumequine, FLU). Results revealed that π-π interactions between g-C₃N₄ and FLU favor electrons delivery, resulting in enhanced charge separation efficiency and direct hole oxidation of FLU. Moreover, it is found that the charge transfer rate is determined by the valence band (VB) level of g-C₃N₄ and E_HOMO of FLU, of which the deeper VB position of g-C₃N₄ favors faster charge transfer, leading to further enhancement in photocatalytic degradation rate of FLU. Additionally, the possible degradation pathways of FLU were proposed by theoretical calculation and the determined intermediates. Our work afforded a new insight into pollutants degradation and the rational design of highly efficient photocatalysts.

Distribution of Flumequine in Intestinal Contents and Colon Tissue in Pigs after Its Therapeutic Use in the Drinking Water

Simple Summary

Gastrointestinal diseases are relatively common in pigs, and cause important economic losses. These disorders include, among others, swine dysentery, a severe diarrheal disease in growing and finisher pigs caused by Brachyspira hyodysenteriae. Flumequine, a fluoroquinolone indicated in the treatment of colibacillosis, enteritis and gastroenteritis, may help to minimize the impact of swine dysentery. Thus, the objective of this study was to assess flumequine concentrations in pig plasma, colon tissue and intestinal contents following oral administration through drinking water, and determine if it would be effective against the sensitive bacteria found in the colon. The drug was not detected in any plasma sample, while concentrations were higher on the days of treatment than after having finished it. Concentrations achieved in colon tissue and intestinal contents were lower than those effective against the most common intestinal pathogenic microorganisms in swine, including B. hyodysenteriae, suggesting that this dosage would not be effective.

Abstract

Flumequine concentrations in plasma, colon tissue and intestinal contents were evaluated in 12 healthy pigs after oral administration (12 mg/kg every 24 h for 5 consecutive days in drinking water). Plasma, colon tissue and intestinal content samples were collected from animals sacrificed on days 3, 6 and 7. Concentrations were measured by high performance liquid chromatography after having validated the method, following the European Medicines Agency (EMA) requirements. The drug was not detected in any plasma sample. In colon tissue, concentrations were higher on day 3 (0.230 ± 0.033 µg/g, descending colon; 0.156 ± 0.093 µg/g, ascending colon) than on day 6 (0.187 ± 0.123 µg/g, descending colon; 0.107 ± 0.007 µg/g, ascending colon). Concentrations were considerably higher in intestinal contents, again on day 3 (1.349 ± 1.401 µg/g, descending colon; 0.591 ± 0.209 µg/g, ascending colon) than on days 6 (0.979 ± 0.346 µg/g, descending colon; 0.595 ± 0.075 µg/g, ascending colon) and 7 (0.247 ± 0.172 µg/g, descending colon; 0.172 ± 0.086 µg/g, ascending colon). Measured concentrations were lower than those effective against the most common intestinal pathogenic microorganisms in swine and, more specifically, Brachyspira hyodysenteriae.

Evaluation of the in vitro activity of flumequine against field isolates of Brachyspira hyodysenteriae

Flumequine is a quinolone derivative used in veterinary medicine to treat enteric infections, mainly those caused by Gram negative bacteria and also some Gram positive. Some recent reports by field practitioners have suggested that its use in swine dysentery outbreaks can minimize the impact of this disease. This study aims to evaluate the in vitro anti-Brachyspira hyodysenteriae activity of flumequine. Forty eight field isolates of the bacterium were evaluated using a microdilution test. The lack of colon bioavailability studies of flumequine in pigs makes it difficult to establish the true efficacy of this antibiotic for swine dysentery control. Nonetheless, the relatively high values of MIC50 (50 μg/mL) and MBC50 (50 μg/mL) obtained suggest poor activity against B. hyodysenteriae. Flumequine activity in swine dysentery outbreaks could be related to its activity against other bacteria, different from B. hyodysenteriae, engaged in swine dysentery pathogenesis.

Degradation of flumequine by the Fenton and photo-Fenton processes: evaluation of residual antimicrobial activity

Flumequine is a broad-spectrum antimicrobial agent of the quinolone class, and it is widely used as a veterinary drug in food-producing animals. The presence of flumequine in the environment may contribute to the development of drug resistant bacterial strains. In this study, water samples fortified with flumequine (500 μg L(-1)) were degraded using the Fenton and photo-Fenton processes. The maximum degradation efficiency for flumequine by the Fenton process was approximately 40% (0.5 mmol L(-1) Fe(II), 2.0 mmol L(-1) H(2)O(2) and 15 min). By applying UV radiation (photo-Fenton process), the efficiency reached more than 94% in 60 min when 0.25 mmol L(-1) Fe(II) and 10.0 mmol L(-1) H(2)O(2) were used. Under these conditions, the Fenton process was able to reduce the biological activity, whereas the photo-Fenton process eliminated almost all of the antimicrobial activity because it was not detected. Four byproducts with an m/z of 244, 238, 220 and 202 were identified by mass spectrometry, and a degradation pathway for flumequine was proposed. The byproducts were derived from decarboxylation and defluorination reactions and from modifications in the alkylamino chain of the fluoroquinolone.